Latest data from June 17, 2022
Number of Health Center respondents = 25 (83% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
Metrics | Value |
---|---|
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 2,028 |
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 45.96% |
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 418 |
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 43.42% |
Patients by Race and Ethnicity
Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
---|---|---|
White, Non-Hispanic/Latino Patients | 50.49% | 51.44% |
White, Hispanic/Latino Patients | 20.12% | 26.08% |
Black/African American, Non-Hispanic/Latino Patients | 2.37% | 2.15% |
Black/African American, Hispanic/Latino Patients | 0.05% | 0.00% |
Asian Patients3 | 2.91% | 1.67% |
American Indian/Alaska Native Patients3 | 8.14% | 1.44% |
Native Hawaiian/Other Pacific Islander Patients3 | 0.25% | 0.96% |
Patients with More Than One Race3 | 3.45% | 2.15% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 5.67% | 5.02% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 1.43% | 1.67% |
Unreported/Refused to Report Race and Ethnicity | 5.13% | 7.42% |
Patients Vaccinated
Metrics | Value |
---|---|
COVID-19 Immunization Series Initiated | 406 |
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 59.62% |
COVID-19 Immunization Series Completed | 441 |
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 56.47% |
COVID-19 Immunization Series Additional | 1,542 |
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 38.54% |
Vaccinations by Race and Ethnicity
Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
---|---|---|---|
White, Non-Hispanic/Latino Patients | 36.70% | 39.68% | 55.32% |
White, Hispanic/Latino Patients | 23.40% | 21.32% | 19.13% |
Black/African American, Non-Hispanic/Latino Patients | 8.87% | 8.39% | 2.01% |
Black/African American, Hispanic/Latino Patients | 0.25% | 0.45% | 0.06% |
Asian Patients3 | 4.93% | 6.12% | 2.46% |
American Indian/Alaska Native Patients3 | 3.20% | 2.04% | 1.69% |
Native Hawaiian/Other Pacific Islander Patients3 | 1.97% | 0.68% | 0.52% |
Patients with More Than One Race3 | 1.48% | 1.36% | 1.56% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 10.10% | 11.11% | 7.26% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.22% | 2.27% | 2.08% |
Unreported/Refused to Report Race and Ethnicity | 6.90% | 6.58% | 7.91% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
Metrics | Value |
---|---|
Less Than 1 Hour | 28.00% |
1 to 24 Hours | 24.00% |
More Than 24 Hours | 40.00% |
N/A | 8.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
Metrics | Value |
---|---|
Financial reimbursement for costs associated with vaccine administration | 4.00% |
Staffing to administer the vaccine | 20.00% |
Vaccine confidence | 28.00% |
Vaccine storage capacity | 0.00% |
Vaccine supply | 0.00% |
Other | 0.00% |
None | 56.00% |
Operations and Staff
Metrics | Value |
---|---|
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 8.00% |
Average Percent of Health Center Visits Conducted Virtually | 19.00% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
Metrics | Value |
---|---|
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 20.00% |
Number of Mobile Van Sites | 20 |
Number of Pop-up Clinics | 0 |
Number of School-Based Vaccination Sites | 13 |
Number of Family Vaccination Clinics | 28 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Direct provision of monoclonal antibody therapies | 24.00% |
Refer patients to another organization that provides monoclonal antibody therapies | 44.00% |
None | 36.00% |
Challenges in Providing Access to Monoclonal Antibody Therapy
Metrics | Value |
---|---|
Access to therapeutics | 8.00% |
Patient awareness/education | 4.00% |
Staffing capacity | 12.00% |
Therapy administration/onsite logistics | 16.00% |
Other | 8.00% |
None | 64.00% |
Test Kit Distribution
Metrics | Value |
---|---|
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 14 |
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 3,404 |
Test Kit Distribution Methods4
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 57.14% |
Provided to General Public Who Came to the Health Center | 57.14% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 7.14% |
Provided at Other Community Events | 7.14% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 7.14% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 7.14% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to school-age children and/or their families directly or through partnerships with schools | 7.14% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
Other | 21.43% |
N95 Mask Distribution
Metrics | Value |
---|---|
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 7 |
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 3,774 |
N95 Mask Distribution Methods5
Metrics | Value |
---|---|
Provided to Existing Health Center Patients | 71.43% |
Provided to General Public Who Came to the Health Center | 71.43% |
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 14.29% |
Provided at Other Community Events | 0.00% |
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 14.29% |
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 14.29% |
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 0.00% |
Provided to school-age children and/or their families directly or through partnerships with schools | 0.00% |
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 0.00% |
Other | 0.00% |
Oral Antiviral Medication Distribution
Metrics | Value |
---|---|
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 7 |
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 31.67% |
Oral Antiviral Medication Distribution by Race and Ethnicity
Race/Ethnicity | Value |
---|---|
White, Non-Hispanic/Latino Patients | 54.17% |
White, Hispanic/Latino Patients | 20.83% |
Black/African American, Non-Hispanic/Latino Patients | 0.00% |
Black/African American, Hispanic/Latino Patients | 0.00% |
Asian Patients3 | 5.00% |
American Indian/Alaska Native Patients3 | 1.67% |
Native Hawaiian/Other Pacific Islander Patients3 | 1.67% |
Patients with More Than One Race3 | 0.00% |
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.50% |
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.00% |
Unreported/Refused to Report Race and Ethnicity | 14.17% |
Oral Antiviral Medication Distribution by Population Type
Metrics | Value |
---|---|
Migratory/Agricultural Workers | 16.67% |
Patients Experiencing Homelessness | 4.17% |
Patients Who Are Residents of Public Housing | 10.83% |
Patients with Limited English Proficiency | 15.83% |
Children Under 18 Years of Age | 8.33% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.